Physician profile
Athanasios Stoyioglou
NPI 1427139476
$2,622.58
in general payments reported to CMS, 2019-2025
21 companies · $905 in 2025
The $905 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $80.99 · 2021: $195 · 2022: $226 · 2023: $532 · 2024: $486 · 2025: $905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $416.03 | 2025 | Flowtriever, Clottriever Bold Catheter, Artix Mt |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $410.16 | 2020-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $288.33 | 2019-2025 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $219.00 | 2021-2023 | Xarelto |
| Abiomed | $204.18 | 2025 | |
| Inari Medical, INC. | $187.74 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $147.10 | 2021 | |
| Tactile Systems Technology INC | $134.10 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Boston Scientific Corporation | $128.87 | 2019-2024 | Watchman Flx, Watchman |
| Novartis Pharmaceuticals Corporation | $123.18 | 2023-2025 | |
| Amgen INC. | $119.26 | 2019-2020 | |
| Heartflow, INC. | $54.22 | 2025 | |
| Angiodynamics, INC. | $49.99 | 2024 | Auryon Laser System 100-120 Vac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.04 | 2023 | Jardiance |
| Cardiva Medical, INC. | $21.56 | 2025 | Optowire |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $19.38 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $18.84 | 2025 | Opsynvi, Uptravi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.64 | 2019 | |
| Terumo Medical Corporation | $13.21 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.95 | 2019 | |
| Pfizer INC. | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Athanasios Stoyioglou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.